SEALSQ (LAES) had the highest return between December 27, 2023 and January 15, 2024 by a small-cap US stock, returning 101.8%.
| ASSET | DATE | % RETURN |
|---|---|---|
SEALSQ (LAES) | 12/27/2023 - 1/15/2024 | 101.79% |
Katapult Holdings Equity Warrants Exp 09 June 2026 (KPLTW) | 12/27/2023 - 1/15/2024 | 95% |
Praxis Precision Medicines (PRAX) | 12/27/2023 - 1/15/2024 | 89.89% |
QuantaSing Group Limited American Depositary Shares (QSG) | 12/27/2023 - 1/15/2024 | 59.64% |
Clene (CLNNW) | 12/27/2023 - 1/15/2024 | 51.72% |
Richtech Robotics Inc Class B Common Stock (RR) | 12/27/2023 - 1/15/2024 | 44.67% |
ATAI Life Sciences (ATAI) | 12/27/2023 - 1/15/2024 | 44.12% |
Real Brokerage (REAX) | 12/27/2023 - 1/15/2024 | 42.04% |
Qilian International (BGM) | 12/27/2023 - 1/15/2024 | 41.51% |
Establishment Labs (ESTA) | 12/27/2023 - 1/15/2024 | 40.05% |
Ardelyx (ARDX) | 12/27/2023 - 1/15/2024 | 38.28% |
POET Technologies (POET) | 12/27/2023 - 1/15/2024 | 37.78% |
Sana Biotechnology (SANA) | 12/27/2023 - 1/15/2024 | 36.9% |
Corvus Pharmaceuticals (CRVS) | 12/27/2023 - 1/15/2024 | 34.48% |
Yirendai (YRD) | 12/27/2023 - 1/15/2024 | 34.21% |
Verastem (VSTM) | 12/27/2023 - 1/15/2024 | 33.21% |
Amarin (AMRN) | 12/27/2023 - 1/15/2024 | 31.96% |
Dyne Therapeutics (DYN) | 12/27/2023 - 1/15/2024 | 30.7% |
Keros Therapeutics (KROS) | 12/27/2023 - 1/15/2024 | 29.53% |
Aeva Technologies, Inc Common Stock (AEVA) | 12/27/2023 - 1/15/2024 | 29.44% |
Immunome (IMNM) | 12/27/2023 - 1/15/2024 | 29.27% |
Y mAbs Therapeutics (YMAB) | 12/27/2023 - 1/15/2024 | 29.18% |
ADC Therapeutics (ADCT) | 12/27/2023 - 1/15/2024 | 29.09% |
I-Mab (IMAB) | 12/27/2023 - 1/15/2024 | 28.93% |
Aquestive Therapeutics (AQST) | 12/27/2023 - 1/15/2024 | 28.92% |
Small-cap stocks are treated as having a market cap between $300M and $2B.
